Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?

Neurology. 2004 Jun 22;62(12):2313-5. doi: 10.1212/01.wnl.0000130500.44011.75.

Abstract

The authors examined the relationships between sex and race and antithrombotics prescribed at discharge in the Michigan Medicare population using retrospective medical record abstraction (n = 2,715) for the period January 1, 2001, to June 30, 2001. There were no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Black or African American / statistics & numerical data*
  • Comorbidity
  • Drug Utilization / statistics & numerical data
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Ischemic Attack, Transient / drug therapy*
  • Ischemic Attack, Transient / epidemiology
  • Male
  • Medicare
  • Michigan
  • Patient Discharge
  • Stroke / drug therapy*
  • Stroke / epidemiology
  • Thrombolytic Therapy / statistics & numerical data*
  • White People / statistics & numerical data*

Substances

  • Fibrinolytic Agents